AMP recommends minimum set of pharmacogenetic alleles to help standardize clinical genotyping testing for warfarin response

AMP has published consensus, evidence-based recommendations to aid in the design, validation and interpretation of clinical genotyping tests for the prediction of warfarin response. The manuscript, ‘Recommendations for Clinical Warfarin Sensitivity Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists,’ was released online ahead of publication in The Journal of Molecular Diagnostics.